Advanced search
Publication Cover
Expert Opinion on Drug Delivery Volume 17, 2020 - Issue 7
Submit an article Journal homepage
256
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Harnessing CD47 mimicry to inhibit phagocytic clearance and enhance anti-tumor efficacy of nanoliposomal doxorubicin

Seyed Mohammad Gheibi Hayata Department of Medical Biotechnology, Faculty Medicine, Mashhad University of Medical Sciences, Mashhad, IranView further author information
,
Mahmoud R. Jaafarib Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran;c Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, IranView further author information
,
Mahdi Hatamipourc Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, IranView further author information
,
Tannaz Jamialahmadid Department of Food Science and Technology, Quchan Branch, Islamic Azad University, Quchan, Iran;e Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IranView further author information
&
Amirhossein Sahebkarf Halal Research Center of IRI, FDA, Tehran, Iran;g Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran;h School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, IranCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0002-8656-1444View further author information
ORCID Icon
Pages 1049-1058 | Received 24 Feb 2020, Accepted 19 May 2020, Published online: 16 Jun 2020

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Rui Ma, Jingxue Nai, Jinbang Zhang, Zhiping Li, Fenghua Xu & Chunsheng Gao. (2021) Co-delivery of CPP decorated doxorubicin and CPP decorated siRNA by NGR-modified nanobubbles for improving anticancer therapy. Pharmaceutical Development and Technology 26:6, pages 634-646.
Read now

Articles from other publishers (11)

Elizaveta N. Mochalova, Elena A. Egorova, Kristina S. Komarova, Victoria O. Shipunova, Nelli F. Khabibullina, Petr I. Nikitin & Maxim P. Nikitin. (2023) Comparative Study of Nanoparticle Blood Circulation after Forced Clearance of Own Erythrocytes (Mononuclear Phagocyte System-Cytoblockade) or Administration of Cytotoxic Doxorubicin- or Clodronate-Loaded Liposomes. International Journal of Molecular Sciences 24:13, pages 10623.
Crossref
Jihoon Lee, Min-Koo Choi & Im-Sook Song. (2023) Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting. Pharmaceuticals 16:6, pages 802.
Crossref
Amir R. Afshari, Mehdi Sanati, Hamid Mollazadeh, Prashant Kesharwani, Thomas P. Johnston & Amirhossein Sahebkar. (2022) Nanoparticle-based drug delivery systems in cancer: A focus on inflammatory pathways. Seminars in Cancer Biology 86, pages 860-872.
Crossref
Sedighe Forouhari, Zahra Beygi, Zahra Mansoori, Sara Hajsharifi, Fatemeh Heshmatnia & Seyed Mohammad Gheibihayat. (2021) Liposomes: Ideal drug delivery systems in breast cancer. Biotechnology and Applied Biochemistry 69:5, pages 1867-1884.
Crossref
Junqiao Zhu, Chengyuan Cai, Jiaxin Li, Jisheng Xiao & Xiaopin Duan. (2022) CD47-SIRPα axis in cancer therapy: Precise delivery of CD47-targeted therapeutics and design of anti-phagocytic drug delivery systems. Medicine in Drug Discovery 15, pages 100139.
Crossref
Raquel Taléns-Visconti, Octavio Díez-Sales, Jesus Vicente de Julián-Ortiz & Amparo Nácher. (2022) Nanoliposomes in Cancer Therapy: Marketed Products and Current Clinical Trials. International Journal of Molecular Sciences 23:8, pages 4249.
Crossref
Patrick M. Glassman, Elizabeth D. Hood, Laura T. Ferguson, Zongmin Zhao, Don L. Siegel, Samir Mitragotri, Jacob S. Brenner & Vladimir R. Muzykantov. (2021) Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers. Advanced Drug Delivery Reviews 178, pages 113992.
Crossref
Zahra Beizavi, Seyed Mohammad Gheibihayat, Hadis Moghadasian, Hossein Zare, Babak Shirazi Yeganeh, Hassan Askari, Sina Vakili, Amir Tajbakhsh & Amir Savardashtaki. (2021) The regulation of CD47-SIRPα signaling axis by microRNAs in combination with conventional cytotoxic drugs together with the help of nano-delivery: a choice for therapy?. Molecular Biology Reports 48:7, pages 5707-5722.
Crossref
Seyed Mohammad Gheibihayat, Mahmoud R Jaafari, Mahdi Hatamipour & Amirhossein Sahebkar. (2021) Improvement of the pharmacokinetic characteristics of liposomal doxorubicin using CD47 biomimickry. Journal of Pharmacy and Pharmacology 73:2, pages 169-177.
Crossref
Wei-Bang Yu, Zi-Han Ye, Xiuping Chen, Jia-Jie Shi & Jin-Jian Lu. (2021) The development of small-molecule inhibitors targeting CD47. Drug Discovery Today 26:2, pages 561-568.
Crossref
Jeniffer D. Loaiza Naranjo, Anne-Sophie Bergot, Irina Buckle & Emma E. Hamilton-Williams. (2020) A Question of Tolerance—Antigen-Specific Immunotherapy for Type 1 Diabetes. Current Diabetes Reports 20:12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.